Scaling Bio-Based Innovations: A Strategic Blueprint of Funding Instruments and Regulatory Pathways

This study examines how private investment, public grants, and hybrid public–private mechanisms shape the scale-up of bio-based innovations in Europe. It addresses Europe’s circular-economy goals and the valorization of biomass residues, elucidating the factors contributing to the scale-up gap evidenced in this work: 40% of funded finished projects surveyed did not reach the market. A mixed-methods cascade approach was applied. Firstly, a comparative review of European and U.S. scale-up, a mapping of policies, regulatory frameworks and funding instruments was performed. Secondly, a survey of 97 stakeholders on perceived barriers, success factors, and incentives as well as four in-depth expert interviews were conducted across 7 industrial sectors and different typology of organizations. Findings reveal sector- and organization-specific challenges and enablers. European SMEs invest less in bio-based R&D, while U.S. private mechanisms (VC rounds, green bonds) deliver strong outcomes at TRL 7–9 when cluster-based. European public entities outperform in securing scale-up grants, and blended-finance models combining public de-risking with private equity are recommended tailored to the maturity of the project. Respondents prioritize fiscal reductions, outcome-based subsidies, and flexible certification pathways to strengthen Europe’s bio-based industry and strategic autonomy. This research offers actionable guidance for policymakers to refine incentive structures, for investors to evaluate opportunities systematically, and for SMEs to navigate the scale-up challenge, thereby strengthening Europe’s strategic autonomy in sustainable innovation.